Galenica’s Swiss consumer healthcare operation Verfora has its expanded its portfolio with the acquisition of herbals specialist Padma AG for an undisclosed sum.
Based in Wetzikon, Switzerland, Padma manufactures and distributes OTC drugs and food supplements derived from Tibetan medicine. The company generates sales at retail prices of around CHF10m annually in its home market, accounting for around 70% of its turnover
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?